Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07419581 · ClinicalTrials.gov registry record · NA
A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment
A NA study, sponsored by Case Comprehensive Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07419581 is a NA study that has not yet begun recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 45 participants.
The verdict
NCT07419581, a NA study, has not yet begun recruiting, sponsored by Case Comprehensive Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study is for people with a diagnosis of solid tumor cancer who are experiencing changes in taste perception due to cancer treatment. Changes in taste perception, also known as dysgeusia, is a frequent side effect of cancer treatment and can significantly impacts quality of life. These alterations may be temporary or, in some cases, permanent. The purpose of this study is determine whether freeze dried miracle fruit, marketed as MiraBurst can improve taste perception in this group of people. Participants involved in this study will be asked to take one MiraBurst mini-square upto four times a day, prior to eating, for 90 days.
Interventions
- DIETARY_SUPPLEMENT MiraBurst
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07419581
The ClinicalTrials.gov registry entry for NCT07419581 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MiraBurst is the first listed.
NCT07419581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07419581 about?
NCT07419581 is a clinical study titled "A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment". This study is for people with a diagnosis of solid tumor cancer who are experiencing changes in taste perception due to cancer treatment. Changes in taste perception, also known as dysgeusia, is a frequent side effect of cancer treatment and can significantly impacts quality of life. These alteratio...
What is the current status of trial NCT07419581?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-06. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07419581?
The interventions under investigation include: MiraBurst (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07419581?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.